Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Combining BET inhibition with SMAC mimetics restricts tumor growth and triggers immune surveillance in preclinical cancer models.
Journal: Cell reports. Medicine
Published: August 05, 2024
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients.
Journal: Oncoimmunology
Published: September 14, 2020
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients.
Journal: Journal for immunotherapy of cancer
Published: November 14, 2018
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: September 06, 2018
Showing 1-4 of 4
Last Updated: 09/26/2026